Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

10.06p
   
  • Change Today:
      0.050p
  • 52 Week High: 21.25
  • 52 Week Low: 8.80
  • Currency: UK Pounds
  • Shares Issued: 139.47m
  • Volume: 177,080
  • Market Cap: 14.02m
  • RiskGrade: 515
  • Beta: 0.01

Immupharma Overview

Immupharma is in the pharma and biotech sector and is currently trading at 10.06p per share. In the last year Immupharma's share price has ranged from 8.80p to 21.25p and brokers are currently rating this stock as 'strong sell'.

1 Day Chart (19-07-2019)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -9941.0% -4880.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 172.5 140.2
Pr/Book 1.8  
Latest F'cast
Revenue -46.0% 23.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Immupharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 0.18 (3.34) (3.43)p n/a n/a n/a n/a 0.0%
31-Dec-15 0.08 (4.55) (4.40)p n/a n/a n/a n/a 0.0%
31-Dec-16 0.16 (6.31) (4.54)p n/a n/a n/a n/a 0.0%
31-Dec-17 0.15 (7.00) (4.75)p n/a n/a n/a n/a 0.0%
31-Dec-18 0.08 (7.96) (5.19)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Immupharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.10 (4.88) (2.87)p n/a n/a n/a n/a 0.0%
31-Dec-20 0.10 (5.11) (2.76)p n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Immupharma Company Announcements

TR-1: notification of major holdings 04-Jul-2019 07:00 RNS
TR-1: notification of major holdings 02-Jul-2019 15:33 RNS
Update on Lupuzor 28-Jun-2019 07:00 RNS

Latest Immupharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Immupharma Market Data

Currency UK Pounds
Share Price 10.06p
Change Today 0.050p
% Change 0.50 %
52 Week High 21.25
52 Week Low 8.80
Volume 177,080
Shares Issued 139.47m
Market Cap 14.02m
Beta 0.01
RiskGrade 515

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.39% below the market average36.39% below the market average36.39% below the market average36.39% below the market average36.39% below the market average
32.20% above the sector average32.20% above the sector average32.20% above the sector average32.20% above the sector average32.20% above the sector average
Price Trend
72.05% below the market average72.05% below the market average72.05% below the market average72.05% below the market average72.05% below the market average
60.66% below the sector average60.66% below the sector average60.66% below the sector average60.66% below the sector average60.66% below the sector average
Income Not Available
Growth
36.19% below the market average36.19% below the market average36.19% below the market average36.19% below the market average36.19% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 0
Sell 0
Strong Sell 1
Total 1
strong_sell
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Immupharma Dividends

No dividends found

Trades for 19-Jul-2019

Time Volume / Share Price
16:29 1,793 @ 9.71p
15:40 1,919 @ 9.88p
14:59 1,000 @ 9.76p
14:59 14,250 @ 9.82p
14:32 551 @ 9.72p

Immupharma Key Personnel

CEO Dimitri Dimitriou

Top of Page